Toll-like receptor 2 ligand, lipoteichoic acid is inhibitory against infectious laryngotracheitis virus infection in vitro and in vivo. Issue 1 (January 2015)

• Record Type: Journal Article
• Authors: Haddadi, S.; Thapa, S.; Kameka, A.M.; Hui, J.; Czub, M.; Nagy, E.; Muench, G.; Abdul-Careem, M.F.
• Is Part Of: Developmental and comparative immunology. Volume 48:Issue 1(2015)
• Page Start: 22
• Page End: 32
• Publication Date: 2015-01
• Subjects: Immunology -- Periodicals; Developmental immunology -- Periodicals; 616.079
• DOI: 10.1016/j.dci.2014.08.011
• Languages: English
• ISSNs: 0145-305X

Abstract

<abstract abstract-type="author-highlights" id="ab0010"> <title id="st0010">Highlights</title> <sec> <p id="sp0010"> <list id="ulist0010"> <list-item id="u0010"> <label></label> <p id="p0010">Lipoteichoic acid (LTA) induces mRNA expression of IL-1 and iNOS in vitro.</p> </list-item> <list-item id="u0015"> <label></label> <p id="p0015">LTA induces mRNA expression of IL-1 in vivo.</p> </list-item> <list-item id="u0020"> <label></label> <p id="p0020">LTA induces macrophage expansion in lungs.</p> </list-item> <list-item id="u0025"> <label></label> <p id="p0025">LTA induces antiviral response in vitro and in vivo.</p> </list-item> </list> </p> </sec> </abstract>